Mexico City /
pharmaceutical Johnson & Johnson intends to launch a vaccine against coronavirus single dose.
It will be in January or February when it will obtain accurate data about its effectiveness, according to the American company.
The final idea is to deliver 1 billion doses of vaccine by the end of 2021; Meanwhile, the New York Times reported that Johnson & Johnson has manufacturing delays.
“We are proposing 1 billion doses in 2021. If it is a single dose, that means 1 billion people. But it will grow throughout the year, “he said. Paul Stoffels, CEO of the pharmaceutical company.
Johnson & Johnson vaccine It is produced in the United States, Europe, South Africa and also in India.
(…)
(…)